Peoples Bank (Kansas)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25
Closed -$708 255
2025
Q1
$708 Hold
25
﹤0.01% 322
2024
Q4
$1.04K Hold
25
﹤0.01% 305
2024
Q3
$1.67K Hold
25
﹤0.01% 299
2024
Q2
$2.97K Buy
25
+10
+67% +$1.26K ﹤0.01% 254
2024
Q1
$1.6K Buy
15
+10
+200% +$1.01K ﹤0.01% 255
2023
Q4
$497 Hold
5
﹤0.01% 263
2023
Q3
$516 Buy
+5
New +$558 ﹤0.01% 256

Other funds holding MRNA

Peoples Bank (Kansas)'s MRNA Position: Q2 2025 in Review

Peoples Bank (Kansas) sold out of Moderna (MRNA) in Q2 2025, closing a stake of 25 shares — an estimated $708 sold.

Peoples Bank (Kansas) first reported a position in MRNA in Q3 2023 and held it in 7 quarters. The position peaked at $2.97K in Q2 2024. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Peoples Bank (Kansas) reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Peoples Bank (Kansas) sold 25 Moderna shares in Q2 2025, an estimated $708.
  • Peoples Bank (Kansas) first reported a position in Moderna in Q3 2023 and held it in 7 quarters.
  • Peoples Bank (Kansas)'s Moderna position peaked at $2.97K in Q2 2024.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2025, filed 10 Jul 2025.